![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-2b7c4033e77019034e26cf7cd10d6ab72b8c84d570987599c73ea0353a15f371.jpg)
Sodium-Glucose Cotransporter-2 Inhibitors for Type 2 Diabetes Mellitus
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.